This webpage contains details of the Serious Shortage Protocols (SSPs) currently in place, including links to relevant guidance. For more general information about what SSPs are and when they may be used, please visit this webpage.
|SSP05: Fluoxetine 10mg tablets
||17th May 2021|
|SSP07: Fluoxetine 30mg capsules||17th May 2021|
|SSP009: Fluoxetine 40mg capsules||17th May 2021|
|SSP010: Levothyroxine 12.5mcg tablets||1st April 2021|
|SSP011: Competact® 15mg/850mg tablets||7th May 2021|
Details will be updated above as and when changes occur, but the most up-to-date information is available from the NHS Business Services Authority (NHSBSA) website.
Guidance and support
If and when an SSP is revoked/expired, it will be removed from the live table above and instead placed below for historical reference.
|SSP08: Salazopyrin® EN-Tabs 500mg||8th March 2021|
|SSP06: Fluoxetine 40mg capsules||2nd October 2020|
|SSP04: Haloperidol 500mcg capsules (Serenace®)||23rd March 2020|
|SSP02: Fluoxetine 30mg capsules||18th December 2019|
|SSP03: Fluoxetine 40mg capsules
||20th November 2019|
|SSP01: Fluoxetine 10mg capsules||25th October 2019|